- Home
- PGC vs IMTX Comparison
PGC vs IMTX Comparison
Compare PGC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGC
- IMTX
- Stock Information
- Founded
- PGC 1921
- IMTX N/A
- Country
- PGC United States
- IMTX Germany
- Employees
- PGC N/A
- IMTX N/A
- Industry
- PGC Commercial Banks
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PGC Finance
- IMTX Health Care
- Exchange
- PGC Nasdaq
- IMTX Nasdaq
- Market Cap
- PGC 540.4M
- IMTX 514.2M
- IPO Year
- PGC N/A
- IMTX N/A
- Fundamental
- Price
- PGC $26.09
- IMTX $4.26
- Analyst Decision
- PGC Strong Buy
- IMTX Strong Buy
- Analyst Count
- PGC 2
- IMTX 4
- Target Price
- PGC $41.50
- IMTX $16.67
- AVG Volume (30 Days)
- PGC 127.2K
- IMTX 849.5K
- Earning Date
- PGC 04-29-2025
- IMTX 05-13-2025
- Dividend Yield
- PGC 0.77%
- IMTX N/A
- EPS Growth
- PGC N/A
- IMTX N/A
- EPS
- PGC 1.85
- IMTX 0.14
- Revenue
- PGC $220,392,000.00
- IMTX $161,336,577.00
- Revenue This Year
- PGC $26.94
- IMTX N/A
- Revenue Next Year
- PGC $15.50
- IMTX $18.80
- P/E Ratio
- PGC $14.10
- IMTX $29.39
- Revenue Growth
- PGC 2.25
- IMTX 188.60
- 52 Week Low
- PGC $20.30
- IMTX $3.30
- 52 Week High
- PGC $37.88
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- PGC 41.05
- IMTX 48.54
- Support Level
- PGC $23.96
- IMTX $4.03
- Resistance Level
- PGC $27.17
- IMTX $4.48
- Average True Range (ATR)
- PGC 1.40
- IMTX 0.39
- MACD
- PGC 0.05
- IMTX 0.05
- Stochastic Oscillator
- PGC 37.90
- IMTX 75.00
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Peapack Private Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and internet banking services. Peapack Private includes asset management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.